Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

33
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
33
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

52
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

23
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

25
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
25
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mechanistic insights into the early life stage microbiota of silver pompano (<i>Trachinotus blochii</i>).

Frontiers in microbiology·2024
Same author

Replacement of failed items in a two commodity retrial queueing-inventory system with multi-component demand and vacation interruption.

Heliyon·2024
Same author

MRI Evidence of Altered Callosal Sodium in Mild Traumatic Brain Injury.

AJNR. American journal of neuroradiology·2018
Same author

Antiinflammatory evaluation of leaves of Plumeria acuminata.

BMC complementary and alternative medicine·2006
Same author

Antioxidant and antimicrobial activities of Bauhinia racemosa L. stem bark.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2005
Same author

Anti-inflammatory, analgesic and antipyretic effects of methanol extract from Bauhinia racemosa stem bark in animal models.

Journal of ethnopharmacology·2005

相关实验视频

Updated: Sep 14, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K

使用混合深度学习和优化技术进行多级联心脏病预测.

K Lakshmanan1, P Gomathi2

  • 1Principal, Sri Durgadevi Polytechnic College, Kavaraipettai, Gummidipoondi, Thiruvellore, Tamil Nadu, India.

Computer methods in biomechanics and biomedical engineering
|July 24, 2025
PubMed
概括

一个新的深度学习模型使用先进的数据处理和特征选择准确预测心脏病. 这种新的方法实现了96.65%的准确性,在早期心脏病检测方面取得了重大进展.

关键词:
心脏病预测 心脏病预测多级联深度学习网络.基于代的突变火与小丑优化.最佳加权的特征是最优的加权特征.

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

相关实验视频

Last Updated: Sep 14, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

科学领域:

  • 人工智能的人工智能
  • 心脏病学 心脏病学
  • 机器学习 机器学习

背景情况:

  • 心脏病仍然是全球死亡的主要原因.
  • 准确和早期预测对于有效的患者管理至关重要.
  • 现有的预测模型经常面临数据复杂性和特征选择的挑战.

研究的目的:

  • 提出一种新的深度学习模型,用于增强心脏病预测.
  • 引入一个优化的特征选择方法,以提高模型性能.
  • 使用基准数据集验证模型的有效性.

主要方法:

  • 使用NaN填充和数据规范化的数据预处理.
  • 通过基于突变代的火与小丑优化 (MI-FHCO) 进行最佳加权特征选择.
  • 使用多级联级深度学习网络 (MDLNet) 预测心脏病.

主要成果:

  • 拟议的深度学习模型在数据集4.4上实现了96.65%的高准确率.
  • MI-FHCO算法有效地确定了预测的最佳特征.
  • MDLNet在心脏病分类方面表现出卓越的表现.

结论:

  • 这种新的深度学习方法为心脏病预测提供了一种高度准确的方法.
  • MI-FHCO特征选择技术提高了模型的特异性和灵敏度.
  • 该模型显示了在早期心脏病检测中临床应用的巨大潜力.